Sten H. Vermund, M.D., Ph.D. (Chair), serves as the dean of the Yale School of Public Health, the Anna M.R. Lauder Professor of Public Health (Epidemiology of Microbial Diseases), and a professor of pediatrics in the Yale School of Medicine. His research has focused on health care access in low-income nations, adolescent sexual and reproductive health, and preventing mother-to-child HIV transmission. Dr. Vermund’s early work included illuminating the importance of HIV infection in human papillomavirus–mediated cervical pathogenesis. He is a member of the National Academy of Medicine. Dr. Vermund received his M.D. from the Albert Einstein College of Medicine at Yeshiva University and his Ph.D. from Columbia University.
Madina Agénor, Sc.D., M.P.H., is the inaugural Gerald R. Gill Assistant Professor of Race, Culture, and Society in the Department of Community Health at Tufts University. She is also the director of the Sexual Health and Reproductive Experiences Lab at Tufts University and adjunct faculty at the Fenway Institute. As a social epidemiologist and health services researcher, Dr. Agénor investigates health and health care inequities in relation to various dimensions of social inequality—especially sexual orientation, gender identity, and race/ethnicity—using an intersectional lens. Specifically, she uses quantitative and qualitative research methods to elucidate the patient-, provider-, and policy-level social determinants of sexual and reproductive health and cancer screening and prevention among marginalized U.S. populations, especially women and girls of
color, sexual minority women and girls, transgender and non-binary individuals, and lesbian, gay, bisexual, transgender, and queer people of color. As the principal investigator of a career development (K01) award from the National Cancer Institute, she is examining how Medicaid state expansions influence sexual orientation and racial/ethnic disparities in human papillomavirus (HPV) vaccination and other sexual and reproductive health outcomes among U.S. women. She is also exploring health care providers’ beliefs, attitudes, decision-making processes, and practices related to HPV vaccination among sexual minority women and women of color in the United States. As a Research Education Institute for Diverse Scholars Fellow at the Center for Interdisciplinary Research on AIDS at Yale University, she is leading a mixed-methods study examining the multi-level social determinants of HIV and sexually transmitted infection testing among transmasculine U.S. young adults. Before joining the Tufts faculty, Dr. Agénor was an assistant professor of social and behavioral sciences at the Harvard T.H. Chan School of Public Health, where she earned an Sc.D. in social and behavioral sciences. She also has an M.P.H. from Columbia University’s Mailman School of Public Health and was a Cancer Prevention Postdoctoral Fellow at the Harvard T.H. Chan School of Public Health and the Dana-Farber Cancer Institute.
Cherrie B. Boyer, Ph.D., FSAHM, is a professor of pediatrics in the Division of Adolescent and Young Adult Medicine at the University of California, San Francisco. She also serves as the associate division director for research and academic affairs. Dr. Boyer is an internationally recognized health psychologist with more than 30 years of research experience in the area of adolescent and young adult health. She has received many grant awards and been a productive investigator, publishing widely in the area of sexually transmitted infections (STIs) and HIV prevention in adolescents and young adults. Dr. Boyer’s research focuses on developing and evaluating cognitive-behavioral and community-level intervention strategies using both culturally competent and positive youth development frameworks to promote sexual health and reduce the risk of STIs, HIV, and unintended pregnancy and their sequelae in adolescents and young adults. Dr. Boyer was a member of the Adolescent Trials Network, funded by the National Institutes of Health, where she served as a lead investigator and collaborated on a number of community-based participatory research community mobilization studies to examine social determinants and structural barriers to improve HIV prevention for at-risk youth and linkage, engagement, and retention in long-term HIV health care for affected youth. She has recently conducted research with the San Francisco Department of Public Health Community Equity Prevention Section to identify and characterize factors associated with the
disproportionately high rate of STIs in African American adolescents in San Francisco. Her other research examines social determinants and other environmental influences on pre-exposure prophylaxis access and uptake in African American and Latin/x young adult men in San Francisco. Dr. Boyer earned her M.A. and Ph.D. from Stony Brook University.
Myron S. Cohen, M.D., is the Yeargan-Bate Eminent Professor of Medicine, Microbiology, and Immunology and a professor of epidemiology at the University of North Carolina (UNC) at Chapel Hill. He is the director of the Institute for Global Health and Infectious Diseases. Dr. Cohen is also the associate director of the UNC Center for AIDS Research and Associate Vice Chancellor for Global Health and Medical Affairs. Dr. Cohen’s research focuses on HIV transmission and prevention, with emphasis on the role played by sexually transmitted infections (STIs) and coinfections. Dr. Cohen is the architect and the principal investigator (PI) of the multinational HIV Prevention Trials Network study (HPTN052) that demonstrated that antiretroviral treatment prevents the sexual transmission of HIV-1. He is a member of the American Society of Clinical Investigation, the American Association of Physicians, and the National Academy of Medicine. He earned his M.D. from Rush Medical College. Dr. Cohen directed the first National Institutes of Health (NIH) STI Clinical Trials Group. Most recently, Dr. Cohen has served as the co-PI of the NIH HIV Prevention Trials Network. Dr. Cohen was on the NIH AIDS Research Advisory Council and the NIH Office of AIDS Research Council and currently serves on the Council of the NIH Fogarty International Center.
Jeffrey S. Crowley, M.P.H., is a distinguished scholar and the program director of infectious disease initiatives at the O’Neill Institute for National and Global Health Law at Georgetown Law. Mr. Crowley is a widely recognized expert on HIV/AIDS and disability policy. His research has covered a range of health policy issues, with an emphasis on Medicaid and Medicare policy, especially as these programs impact people with HIV and other disabilities. Mr. Crowley previously served as the director of the White House Office of National AIDS Policy and the senior advisor on disability policy for President Barack Obama, where he led the development of the first domestic National HIV/AIDS Strategy. He also coordinated disability policy development for the Domestic Policy Council and worked on the policy team that spearheaded the development and implementation of the Patient Protection and Affordable Care Act. Mr. Crowley has also served as an informal resource and counsel for congressional staff, and he advised national consumer coalitions, including the HIV Health Care Access Working Group and the Consortium for Citizens with Disabilities. He is an alumnus of the U.S. Peace Corps, where he was
a volunteer/high school science teacher in eSwatini. Mr. Crowley received his M.P.H. from the Johns Hopkins Bloomberg School of Public Health.
Charlotte A. Gaydos, Dr.P.H., M.S., M.P.H., is a professor emerita in the Division of Infectious Diseases of the Johns Hopkins University School of Medicine. She has joint appointments in emergency medicine and epidemiology and population and family health at the Johns Hopkins Bloomberg School of Public Health. She is a member of the Johns Hopkins University Center for Global Health and former director for the National Institutes of Health–funded Center for Point-of-Care Tests for Sexually Transmitted Diseases and the International STI, Respiratory Diseases, and Biothreat Research Laboratory at Johns Hopkins. She has 50 years of laboratory expertise in microbiology. Dr. Gaydos conducted multiple Food and Drug Administration clinical trials for new diagnostics for sexually transmitted infections (STIs) and respiratory pathogens. Her laboratory has been a core diagnostic/reference laboratory for international studies of STIs, respiratory diseases, and trachoma. Dr. Gaydos has extensive laboratory experience in developing and evaluating molecular amplification testing techniques for respiratory, urogenital, and biothreat specimens, as well as epidemiology expertise. Dr. Gaydos has performed original research developing DNA amplification tests for Chlamydia trachomatis, C. pneumoniae, C. psittaci, Trichomonas vaginalis, N. gonorrhoeae, Mycoplasma genitalium, and the agents of genital ulcer disease. She invented, developed, and published on an STI educational and home screening website, “I Want the Kit,” which has screened more than 10,000 persons with at-home, self-collected urogenital, rectal, and oropharyngeal samples. Dr. Gaydos received her M.S. from West Virginia University and her M.P.H. and Dr.P.H. from the Johns Hopkins Bloomberg School of Public Health.
Vincent Guilamo-Ramos, Ph.D., M.P.H., L.C.S.W., R.N., ANP-BC, PMHNP-BC, AAHIVS, FAAN, is a professor and an associate vice provost of mentoring and outreach programs at New York University (NYU). He is the director and the founder of the Center for Latino Adolescent and Family Health. Dr. Guilamo-Ramos also serves as the pilot and mentoring core director at the Center for Drug Use and HIV Research, a National Institute on Drug Abuse–funded center at the NYU School of Public Health. As of July 1, 2021, Dr. Guilamo-Ramos will be the dean of the Duke University School of Nursing and the vice chancellor for nursing affairs. Dr. Guilamo-Ramos is a clinical social worker and a nurse practitioner and is board certified in HIV/AIDS nursing and as an HIV specialist. Clinically, he has expertise in the primary care of HIV-positive adolescents, pre-exposure prophylaxis for youths at risk of HIV, and screening and treatment of sexually transmitted diseases. Dr. Guilamo-Ramos studies
the role of families in promoting adolescent health, with a special focus on preventing HIV/AIDS, sexually transmitted infections, and unplanned pregnancies and improving treatment outcomes for youth living with HIV and those at risk. He is a fellow of the American Academy of Nursing and the American Academy of Social Work and Social Welfare. In addition, Dr. Guilamo-Ramos serves as a member of the Health and Human Services (HHS) Presidential Advisory Council on HIV/AIDS and the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents. He is also the vice chair of the board of directors for the Latino Commission on AIDS and a board member of Power to Decide. Dr. Guilamo-Ramos received his Ph.D. from the State University of New York at Albany and his M.S.W. and M.P.H. from NYU. He also holds an M.S. from the Robert F. Wagner Graduate School of Public Service at NYU and an M.S.N. from the Duke University School of Nursing.
Edward W. Hook III, M.D., is an emeritus professor of medicine at The University of Alabama at Birmingham (UAB), where he was previously a professor of medicine and microbiology in the School of Medicine and a professor of epidemiology in the School of Public Health. Dr. Hook is the co-director of the university’s Interdisciplinary Center for Social Medicine and STDs. He is also a senior scientist at the UAB AIDS Center, the Minority Health and Research Center, and the Arthritis and Musculoskeletal Disease Center. Dr. Hook was previously the medical director of the sexually transmitted diseases (STDs) control program at the Jefferson County Health Department in Birmingham, where he remains a contract physician. As an internist with subspecialty expertise in infectious diseases, he spent much of his academic career focused on managing and preventing STDs. He has directed public health STD control programs in two cities (Birmingham, Alabama, and Baltimore, Maryland); clinical studies with operational and epidemiologic end points; clinical trials of new diagnostic tests, vaccines, and therapies for a wide variety of STD pathogens; and an internationally recognized reference laboratory for STD pathogens (Neisseria gonorrhoeae, Chlamydia trachomatis, and syphilis). He has served as a consultant and a committee member for a number of national and international organizations, including the National Academies of Sciences, Engineering, and Medicine; National Institutes of Health; Centers for Disease Control and Prevention; and World Health Organization. Before joining UAB, he worked at Johns Hopkins University and with the Baltimore City Health Department. He earned his M.D. from Cornell University.
Patricia Kissinger, Ph.D., M.P.H., B.S.N., is a professor at Tulane University and an infectious disease epidemiologist. She has worked both nationally and internationally for more than three decades in the field
of HIV, sexually transmitted diseases (STDs), and women’s reproductive health in Africa, Haiti, and the United States. Dr. Kissinger focuses on the dynamics of STD/HIV transmission, particularly among vulnerable populations, examining issues of STD/HIV partner notification, expedited partner treatment, sexual networks, substance abuse, pregnancy prevention, and repeat STDs. The ultimate goal of her research is to reduce STD-related health disparities. She has been the principal investigator on dozens of federally funded research grants and published more than 160 manuscripts and numerous book chapters. Dr. Kissinger is a frequent reviewer for the National Institutes of Health, an expert consultant for the Centers for Disease Control and Prevention, and an associate editor of the journal Sexually Transmitted Diseases. She earned her B.S.N. from Marquette University and her M.P.H. and Ph.D. from Tulane University.
Guillermo (“Willy”) J. Prado, Ph.D., is a professor of nursing and health studies, public health sciences, and psychology at the University of Miami, where he also serves as the vice provost for faculty affairs and the dean of the graduate school. Dr. Prado is also the director of the Investigator Development Core for the Center for Latino Health Research Opportunities. Dr. Prado’s research focuses on developing, evaluating, and translating family-based preventive interventions for addressing smoking, alcohol, drug abuse, HIV/sexually transmitted infections, and obesity health disparities among Hispanic youth. His research has been recognized by professional organizations, such as the Society for Prevention Research, the National Hispanic Science Network on Drug Abuse, and the Society for Research on Adolescence. He is currently a board member of Research!America and the president of the Society for Prevention Research. Dr. Prado earned his Ph.D. from the University of Miami.
Cornelis (“Kees”) Rietmeijer, M.D., Ph.D., M.S.P.H., is an independent sexually transmitted infection (STI) consultant. His expertise is in the areas of STI clinical operations and workforce development. He is a professor of community and behavioral health at the Colorado School of Public Health. Until his retirement in 2009, he was the director of the sexually transmitted disease (STD) control program and clinic at the Denver Department of Public Health. As a consultant, he continued to work for the department as the director of the Denver STD Clinical Prevention Training Center until 2020. He is a past president of the American Sexually Transmitted Diseases Association and a past director of the International Union Against STIs—North American Region. Between 2009 and 2016, Dr. Rietmeijer worked and traveled extensively in southern Africa, where he was the director of an HIV/STI prevention course for the Southern African Prevention Initiative and the principal investigator of the
Zimbabwe STI Etiology study, both funded through the President’s Emergency Plan for AIDS Relief. Dr. Rietmeijer is a current associate editor of the journal Sexually Transmitted Diseases, a consultant to the World Health Organization on developing guidelines for STI syndromic management, and a volunteer physician at the Denver STD clinic. Dr. Rietmeijer earned his M.D. and Ph.D. from the University of Amsterdam and his M.S.P.H. from the University of Colorado Denver.
Alina Salganicoff, Ph.D., is the senior vice president and the director of Women’s Health Policy at the Kaiser Family Foundation (KFF). Widely regarded as an expert on women’s health policy, she has written and lectured extensively on health care access and financing for low-income women and children. Her work at KFF focuses on health coverage and access to care for women, with an emphasis on challenges facing low-income and underserved women throughout their life span. Dr. Salganicoff was also an associate director of the Kaiser Commission on Medicaid and the Uninsured and worked on the health program staff of the Pew Charitable Trusts. She has served on numerous federal, state, and nonprofit advisory committees focusing on improving women’s quality of and access to health care, including for the Agency for Healthcare Research and Quality, the Health Resources and Services Administration, the Centers for Disease Control and Prevention, the Department of Veterans Affairs, the Department of Health and Human Services’ Office on Women’s Health, and the National Academies of Sciences, Engineering, and Medicine. She is a member of the advisory panel for the American College of Obstetricians and Gynecologists’ Women’s Preventive Services Initiative and the public policy advisory committee of Power to Decide. Dr. Salganicoff holds a Ph.D. from the Johns Hopkins Bloomberg School of Public Health.
John Schneider, M.D., M.P.H., is a professor of medicine and epidemiology, a network epidemiologist, and an infectious disease specialist in the Departments of Medicine and Public Health Sciences at the University of Chicago. He is also the director of the Chicago Center for HIV Elimination, where he works on developing Getting to Zero strategies informed by social determinants of health integrated within computational models. Dr. Schneider’s research focuses on how social networks can be leveraged to improve the health of community members vulnerable to HIV and other sexually transmitted infections (STIs) in resource-restricted settings, where he also implements network interventions guided by data and community input to eliminate new HIV transmission. Clinically, he specializes in sexual health, HIV/STI prevention and treatment, and gender-affirming care and has a specific interest in providing high-quality
care to sexual and gender minority community members of color. Dr. Schneider has experience with advancing the physician–patient relationship in resource-restricted settings, including at Howard Brown Health 55th Street, where he is the medical director, and during his time working in South India. Dr. Schneider received his M.D. and M.P.H. from Tufts University.
Neeraj Sood, Ph.D., is a professor and the vice dean for faculty affairs and research at the University of Southern California (USC) Sol Price School of Public Policy and a founding member of USC’s Schaeffer Center. He is also a research associate at the National Bureau of Economic Research. Dr. Sood’s research focuses on economic epidemiology, pharmaceutical markets, health insurance, economics of innovation, Medicare, and global health. He has published more than 100 papers in peer-reviewed journals in economics, medicine, and policy. Dr. Sood has testified frequently on health policy issues and has been on expert committees for the National Academies of Sciences, Engineering, and Medicine. His work has been featured in media outlets, including The New York Times, The Washington Post, U.S. News & World Report, and Scientific American. Dr. Sood was the finalist for the 16th and 21st annual National Institute for Health Care Management Health Care Research Award, recognizing outstanding research in health policy. He was awarded the Eugene Garfield Economic Impact Prize, which recognizes outstanding research demonstrating how medical research impacts the economy. Dr. Sood is a board member of the American Society of Health Economists. Before joining USC, he was a senior economist at RAND and a professor at the Pardee RAND Graduate School, where he also received his Ph.D.
Jessica Willoughby, Ph.D., is an associate professor at the Edward R. Murrow College of Communication at Washington State University. Her research focuses on health communication strategies, with an emphasis on adolescents and mobile technologies. Her recent work has been on adolescents’ use of technology for sexual health information, specifically examining the North Carolina BrdsNBz sexual health text message service. Dr. Willoughby previously worked as a research health analyst contracting with the Center for Communication Science at RTI International. She earned her Ph.D. from the University of North Carolina at Chapel Hill.
Sean D. Young, Ph.D., M.S., is an associate professor in the Departments of Emergency Medicine and Informatics at the University of California, Irvine, and the executive director of the University of California Institute for Prediction Technology, which studies how social big data (e.g.,
social media, wearable devices, and online search) and machine learning/data mining can be used to predict real-world events, such as disease outbreaks. Dr. Young’s research focuses on two main areas: (1) using social “big data” and artificial intelligence to monitor and predict public health issues, such as HIV, substance use, and crime; and (2) designing and testing technologies to address public health issues among at-risk populations, including African Americans, Latinx, and men who have sex with men. He is the author of the international best-selling book Stick with It on the science of behavior change. Dr. Young previously worked as a faculty member at the University of California, Los Angeles, School of Medicine and at the NASA Ames Research Center. He received his Ph.D. in psychology and master’s degree in health services research from Stanford University.
Carmen D. Zorrilla, M.D., is a professor of obstetrics and gynecology at the University of Puerto Rico School of Medicine. She is also the principal investigator of the University of Puerto Rico clinical trials unit, which includes adult and pediatric AIDS trials. Certified by the American Board of Obstetrics and Gynecology and the American Academy of HIV Medicine, Dr. Zorrilla has experience in both obstetrics/gynecology and HIV-related research. This work includes behavioral interventions and clinical trials with populations living with HIV or at risk and with pregnant and nonpregnant women. Dr. Zorrilla has participated in diverse clinical and behavioral research projects for women living with HIV. In 1987, she established the first longitudinal clinic for women living with HIV in Puerto Rico and was instrumental in making AZT available to pregnant women living with HIV there. Her clinic, in which more than 600 infants have been born to women living with HIV, has had a nearly zero transmission rate during the past 16 years. Dr. Zorrilla also implemented the first group prenatal care program in Puerto Rico; this new model of care evidenced a reduction in preterm births and low birthweights. She is also one of the leaders who spearheaded the research response to the emerging Zika epidemic among pregnant women in Puerto Rico, and she helped establish a multidisciplinary clinic for these women. Dr. Zorrilla is also evaluating the impact of Hurricane Maria on mothers and infants; her team developed a hurricane preparedness session for pregnant women during group care. Dr. Zorrilla has been a consultant for national and international organizations, including the National Institutes of Health, the Maternal and Child Health Bureau, the Centers for Disease Control and Prevention (CDC), the Agency for Healthcare Research and Quality, and the Institute for Healthcare Improvement. She is also a former member of the Office of Women’s Health Advisory Committee and the CDC/Health Resources and Services Administration AIDS and STD Advisory
Committee and a current member of the National Advisory Council on Minority Health and Health Disparities. Dr. Zorrilla earned her M.D. from the University of Puerto Rico School of Medicine.
Amy B. Geller, M.P.H., serves as the study director for the Committee on Prevention and Control of Sexually Transmitted Infections in the United States and is a senior program officer in the Health and Medicine Division (HMD) on the Board on Population Health and Public Health Practice. At the National Academies, Ms. Geller has staffed committees spanning many topics, including advancing health equity, reducing alcohol-impaired driving fatalities, workforce resilience, vaccine safety, reducing tobacco use, drug safety, and treating posttraumatic stress disorder. She was the study director for the recently released HMD reports Vibrant and Healthy Kids: Aligning Science, Practice, and Policy to Advance Health Equity and Communities in Action: Pathways to Health Equity. She also directs the HMD/National Academy of Medicine DC Public Health Case Challenge, which aims to promote interdisciplinary, problem-based learning for college students at universities in the Washington, DC, area.
Aimee Mead, M.P.H., is an associate program officer on the Board on Population Health and Public Health Practice. She has staffed the National Academies’ consensus reports on eliminating hepatitis B and C in the United States, reducing alcohol-impaired driving, reviewing the public health consequences of e-cigarettes, and evaluating opioid addiction grant programs. She has also supported the Roundtable on Environmental Health Sciences, Research, and Medicine, most recently working on a workshop on the implications of California wildfires. She received her M.P.H. from the Yale School of Public Health and her B.S. from Cornell University.
Sophie Yang is a research associate in the Health and Medicine Division (HMD) on the Board on Population Health and Public Health Practice. She has staffed consensus studies on promoting health equity in the prenatal through early childhood periods, reducing fatalities from alcohol-impaired driving, eliminating hepatitis B and C in the United States, and promoting health equity through community-based solutions. She also staffs the DC Public Health Case Challenge, a joint activity of HMD and the National Academy of Medicine. She received her B.A. in Asian studies and economics from Bowdoin College in 2013.
Harika Dyer, L.L.B., is a senior program assistant in the Health and Medicine Division on the Board on Population Health and Public Health Practice. She supports the Committee on Prevention and Control of Sexually Transmitted Infections in the United States and the Roundtable on Population Health Improvement. She has staffed workshops and webinars on rural health, integrative health care, community-driven initiatives, and COVID-19. Before joining the National Academies, Ms. Dyer worked as a medical scribe and as a sustainability program associate at Booz Allen Hamilton. She received her L.L.B. from the University of the West Indies and her B.A. in political science from Georgia State University.
Hayat Yusuf was a senior program assistant in the Health and Medicine Division on the Board on Population Health and Public Health Practice from March 2019 through March 2020. She supported the Committee on Prevention and Control of Sexually Transmitted Infections in the United States and the Committee on Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action. Ms. Yusuf is currently a program coordinator within the Department of Health Systems Administration at Georgetown University. Before joining the National Acadamies, Ms. Yusuf was a research assistant with Johns Hopkins University conducting data collection for a study that examined intravenous drug use patterns in rural communities and the implementation of a population-level needs assessment for essential public health services.
Rose Marie Martinez, Sc.D., is the senior director of the National Academies’ Board on Population Health and Public Health Practice (1999–pres-ent). The board has a vibrant portfolio of studies that address high-profile and pressing issues that affect population health. The board addresses the science base for population health and public health interventions and examines the capacity of the health system, particularly the public health infrastructure, to support disease prevention and health promotion activities, including educating and supplying the health professionals necessary for carrying them out. The board has examined such topics as the safety of childhood vaccines and other drugs; systems for evaluating and ensuring drug safety after marketing; pandemic influenza planning; the health effects of cannabis and cannabinoids; the health effects of environmental exposures; the integration of medical care and public health; women’s health services; health disparities; health literacy; tobacco control strategies; and chronic disease prevention. Before joining the National Academies, Dr. Martinez was a senior health researcher at Mathematica Policy Research (1995–1999), where she conducted research on the impact of health system change on the public health infrastructure, access to care for low-income populations, managed care, and the health care
workforce. Dr. Martinez is a former assistant director for health financing and policy with the U.S. General Accounting Office, where she directed evaluations and policy analysis in the area of national and public health issues (1988–1995). Her experience also includes 6 years directing research studies for the Regional Health Ministry of Madrid, Spain (1982–1988). Dr. Martinez is a member of the Council on Education for Public Health, the accreditation body for schools of public health and public health programs. Dr. Martinez received her Sc.D. from the Johns Hopkins School of Hygiene and Public Health.